DK0975334T3 - Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler - Google Patents

Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler

Info

Publication number
DK0975334T3
DK0975334T3 DK98918424T DK98918424T DK0975334T3 DK 0975334 T3 DK0975334 T3 DK 0975334T3 DK 98918424 T DK98918424 T DK 98918424T DK 98918424 T DK98918424 T DK 98918424T DK 0975334 T3 DK0975334 T3 DK 0975334T3
Authority
DK
Denmark
Prior art keywords
long
therapeutic agents
term release
biodegradable microparticles
relates
Prior art date
Application number
DK98918424T
Other languages
English (en)
Inventor
Subodh Shah
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/843,975 external-priority patent/US6020004A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0975334T3 publication Critical patent/DK0975334T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
DK98918424T 1997-04-17 1998-04-17 Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler DK0975334T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/843,975 US6020004A (en) 1997-04-17 1997-04-17 Biodegradable microparticles for the sustained delivery of therapeutic drugs
US6166598A 1998-04-16 1998-04-16
PCT/US1998/007856 WO1998046212A1 (en) 1997-04-17 1998-04-17 Biodegradable microparticles for the sustained delivery of therapeutic drugs

Publications (1)

Publication Number Publication Date
DK0975334T3 true DK0975334T3 (da) 2004-01-19

Family

ID=26741350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98918424T DK0975334T3 (da) 1997-04-17 1998-04-17 Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler

Country Status (11)

Country Link
EP (1) EP0975334B1 (da)
JP (1) JP2002514215A (da)
AT (1) ATE252375T1 (da)
AU (1) AU7134898A (da)
CA (1) CA2287534C (da)
DE (1) DE69819145T2 (da)
DK (1) DK0975334T3 (da)
ES (1) ES2205481T3 (da)
HK (1) HK1022265A1 (da)
PT (1) PT975334E (da)
WO (1) WO1998046212A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2236700T3 (es) 1993-11-19 2005-07-16 Janssen Pharmaceutica N.V. 1,2-benzazoles microencapsulados.
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
WO2001030320A1 (en) * 1999-10-22 2001-05-03 Amgen Inc. Biodegradable microparticles with novel erythropoietin stimulating protein
DE60141680D1 (de) * 2000-01-14 2010-05-12 Univ Brown Res Found Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln
US7029700B2 (en) 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
ES2382636T3 (es) 2000-10-31 2012-06-12 Surmodics Pharmaceuticals, Inc. Método para producir composiciones para la administración mejorada de moléculas bioactivas
DE60311801T2 (de) * 2002-05-02 2007-11-08 PR Pharmaceuticals, Inc., Fort Collins Zusammensetzungen aus östradiol-metaboliten mit kontrollierter freisetzung
EP1829529A1 (en) * 2002-05-03 2007-09-05 PR Pharmaceuticals, Inc. Controlled release compositions of estradiol metabolites
US9040664B2 (en) 2003-04-11 2015-05-26 Antriabio, Inc. Materials and methods for preparing protein-polymer conjugates
CN103432079A (zh) 2004-05-12 2013-12-11 巴克斯特国际公司 含有寡核苷酸的微球体及其在制备用于治疗1型糖尿病的药物中的应用
DK2072040T3 (da) 2004-05-12 2013-07-29 Baxter Healthcare Sa Terapeutisk anvendelse af nukleinsyremikrokugler
EP1679065A1 (en) * 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Controlled release compositions for interferon based on PEGT/PBT block copolymers
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
MX2009001226A (es) 2006-08-04 2009-03-20 Baxter Int Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
AU2008242842B2 (en) 2007-04-17 2014-06-05 Baxter Healthcare Sa Nucleic acid microparticles for pulmonary delivery
EP2271324A2 (en) * 2008-05-06 2011-01-12 Glaxo Group Limited Encapsulation of biologically active agents
US20110311630A1 (en) * 2008-06-09 2011-12-22 Boehringer Ingelheim International Gmbh Novel embedment particles for inhalation
KR20100037389A (ko) * 2008-10-01 2010-04-09 연세대학교 산학협력단 다중 약물방출조절이 가능한 솔리드 마이크로구조체 및 이의 제조방법
EP3484450A4 (en) * 2016-07-18 2020-04-01 Tissuegen, Inc. METHODS AND COMPOSITIONS FOR MAINTAINING THE CONFORMATION AND STRUCTURAL INTEGRITY OF BIOMOLECULES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
WO1996022786A1 (en) * 1995-01-23 1996-08-01 Takeda Chemical Industries, Ltd. Sustained-release preparation and use

Also Published As

Publication number Publication date
DE69819145T2 (de) 2004-08-19
ATE252375T1 (de) 2003-11-15
EP0975334B1 (en) 2003-10-22
ES2205481T3 (es) 2004-05-01
EP0975334A1 (en) 2000-02-02
JP2002514215A (ja) 2002-05-14
AU7134898A (en) 1998-11-11
DE69819145D1 (de) 2003-11-27
WO1998046212A1 (en) 1998-10-22
CA2287534A1 (en) 1998-10-22
HK1022265A1 (en) 2000-08-04
PT975334E (pt) 2004-03-31
CA2287534C (en) 2004-12-28

Similar Documents

Publication Publication Date Title
DK0975334T3 (da) Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
DK0993831T3 (da) Forbindelser og præparater til tilförsel af aktive stoffer
DK1283700T3 (da) Farmaceutiske sustained release-præparater til parenteral administration af biologisk aktive hydrofile forbindelser
IL153297A0 (en) Compounds and compositions for delivering active agents
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
PL347671A1 (en) Compounds and compositions for delivering active agents
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
HK1036970A1 (en) Compounds and compositions for delivering active agents.
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
DK1140018T3 (da) Polyol/olie-suspensioner til vedvarende frigørelse af proteiner
DE60024414T2 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
DE59907481D1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
MY140724A (en) Novel arylethene-sulfonamides
DK1189615T3 (da) Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner
HRP20000703B1 (en) Stabile compositions levosimendan and alginic acid
DK0817643T3 (da) Forbindelser og præparater til administration af aktive midler
DE50311479D1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung